Welcome! Login | Register
 

Two Worcester Men Arrested Following Narcotics Deal Near Winslow Park—Two Worcester Men Arrested Following Narcotics Deal Near…

Worcester Man Cited Following Serious Belmont Street Crash That Injured Woman—Worcester Man Cited Following Serious Belmont Street Crash…

Volkswagen Reaches $14.7 Billion Settlement Over Emissions Scandal—Volkswagen Reaches $14.7 Billion Settlement Over Emissions Scandal

Legendary Basketball Coach Pat Summitt Passes Away at 64—Legendary Basketball Coach Pat Summitt Passes Away at…

Horowitz: Military Leaders Making a Difference on Gun Control Debate—Horowitz: Military Leaders Making a Difference on Gun…

States With the Safest Drivers—States With the Safest Drivers

Top Shelf Tuesday - June 28, 2016—Top Shelf Tuesday - June 28, 2016

Organize + Energize: 7 Mini Habits to Practice on a Daily Basis—Organize + Energize: 7 Mini Habits to Practice…

Worcester’s Colorio Is the Big Player in MA Battle to Repeal Common Core—Worcester’s Colorio Is the Big Player in MA…

FBI Files - The Patriarca Papers - Entry 47 (Mob Radio Ad Infuriates Raymond Patriarca)—FBI Files - The Patriarca Papers - Entry…

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.